How would you approach a patient with GCA who develops necrotizing fasciitis and then flares because they are off of tocilizumab?
How would you treat? Would you view tocilizumab as an option in the future?
1 Answer
Mednet MemberInvited Expert
Rheumatology · Massachusetts General Hospital
Answered on
While recurrent necrotizing fasciitis is exceedingly rare, patients with necrotizing fasciitis may be at higher risk for other infections. Therefore, a careful risk/benefit analysis is warranted in such a case, similar to other cases of serious infections in patients on immunosuppression. The specif...
Join for free or sign in to see the full answer